Business Standard

Medicamen Biotech standalone net profit rises 7.87% in the September 2019 quarter

Image

Capital Market

Sales rise 9.33% to Rs 35.52 crore

Net profit of Medicamen Biotech rose 7.87% to Rs 3.84 crore in the quarter ended September 2019 as against Rs 3.56 crore during the previous quarter ended September 2018. Sales rose 9.33% to Rs 35.52 crore in the quarter ended September 2019 as against Rs 32.49 crore during the previous quarter ended September 2018. ParticularsQuarter EndedSep. 2019Sep. 2018% Var.Sales35.5232.49 9 OPM %16.0512.71 -PBDT5.845.59 4 PBT5.225.11 2 NP3.843.56 8

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 08 2019 | 4:44 PM IST

Explore News